Perritt Capital Management Inc Biomerica Inc Transaction History

Perritt Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$0.42 - $0.86 $29,400 - $60,200	70,000 New	70,000 $30,000
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.65 $4,100 - $8,250	-5,000 Reduced 10.53%	42,500 $36,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.87 $22,400 - $37,400	-20,000 Reduced 29.63%	47,500 $64,000
Q1 2023 May 12, 2023	BUY	$1.86 - $3.56 $79,050 - $151,300	42,500 Added 170.0%	67,500 $126,000
Q3 2022 Nov 14, 2022	SELL	$2.61 - $3.98 $13,050 - $19,900	-5,000 Reduced 16.67%	25,000 $98,000
Q1 2021 May 17, 2021	BUY	$5.06 - $8.0 $25,299 - $40,000	5,000 Added 20.0%	30,000 $164,000
Q2 2020 Aug 13, 2020	SELL	$5.17 - $8.95 $25,850 - $44,750	-5,000 Reduced 16.67%	25,000 $181,000
Q1 2020 May 15, 2020	SELL	$2.37 - $16.0 $82,950 - $560,000	-35,000 Reduced 53.85%	30,000 $215,000
Q3 2019 Nov 12, 2019	BUY	$2.59 - $3.53 $64,750 - $88,250	25,000 Added 62.5%	65,000 $211,000
Q4 2018 Feb 08, 2019	BUY	$1.7 - $3.58 $68,000 - $143,200	40,000 New	40,000 $68,000

1.79M

53.7K

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $4.03M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perritt Capital Management Inc with notifications on news.